Lung Neoplasm Clinical Trials in Athens, Attica
4 recruitingAthens, Attica, Greece
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC190 enrolled21 locationsNCT07286149
Recruiting
Phase 2
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Lung Neoplasm Malignant
Merck Sharp & Dohme LLC60 enrolled37 locationsNCT06788912
Recruiting
Phase 2
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Lung Neoplasm
Merck Sharp & Dohme LLC144 enrolled40 locationsNCT06780098
Recruiting
Not Applicable
First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
Pleural Effusion, MalignantMesothelioma, MalignantPleural Effusion+1 more
National and Kapodistrian University of Athens100 enrolled1 locationNCT06946498